Deep Origin Inc.

WOODBURY, NY · Founded 2023 · CIK 0002013862 · Biotech · Private

Physics-based AI platform that simulates molecular properties to accelerate drug discovery

deeporigin.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$29M
1 Form D · Apr 2024
30 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$29,035,704
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2307Gatehouse Bio, Inc.—$5.4M
2308Synlico Inc.—$5.2M
2309Humonix Biosciences Inc——
2310Deep Origin Inc.—$29M
2311Vivace Therapeutics—$61M
2312Volta Labs, Inc.—$29M
2313FabricNano Inc.—$21M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Michael AntonovDirector · Executive Officer
  • Garegin PapoianDirector
  • Dmitriy Matthew ShlosbergDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.